Paper324783
Plasmodium berghei: immunization of mice against the ANKA strain using the unaltered sporozoite as an antigen.
Beaudoin RL and 3 others. Exp Parasitol, 1977. Cited by 86 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Plasmodium berghei: immunization of mice against the ANKA strain using the unaltered sporozoite as an antigen. Papers, record 324783. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/324783
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Plasmodium berghei: immunization of mice against the ANKA strain using the unaltered sporozoite as an antigen.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigens | Major topic |
| Immunization | Major topic |
| Malaria | Major topic |
| Plasmodium berghei | Major topic |
| Animals | |
| Immunity | |
| Mice |
Source PubMed
Cited by46
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 86 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,023,197 | Complete attenuation of Plasmodium falciparum sporozoites by atovaquone-proguanil. | EMBO Mol Med | 2025 | https://conductscience.org/library/papers/41023197 | PubMed |
| 40,424,562 | Long lived liver-resident memory T cells of biased specificities for abundant sporozoite antigens drive malaria protection by radiation-attenuated sporozoite vaccination. | PLoS Pathog | 2025 | https://conductscience.org/library/papers/40424562 | PubMed |
| 37,680,630 | Induction of liver-resident memory T cells and protection at liver-stage malaria by mRNA-containing lipid nanoparticles. | Front Immunol | 2023 | https://conductscience.org/library/papers/37680630 | PubMed |
| 37,571,809 | Sporozoite immunization: innovative translational science to support the fight against malaria. | Expert Rev Vaccines | 2023 | https://conductscience.org/library/papers/37571809 | PubMed |
| 36,593,995 | Antibody-dependent immune responses elicited by blood stage-malaria infection contribute to protective immunity to the pre-erythrocytic stages. | Curr Res Immunol | 2023 | https://conductscience.org/library/papers/36593995 | PubMed |
| 36,159,849 | Five decades of clinical assessment of whole-sporozoite malaria vaccines. | Front Immunol | 2022 | https://conductscience.org/library/papers/36159849 | PubMed |
| 35,641,527 | Efficacy, T cell activation and antibody responses in accelerated Plasmodium falciparum sporozoite chemoprophylaxis vaccine regimens. | NPJ Vaccines | 2022 | https://conductscience.org/library/papers/35641527 | PubMed |
| 35,357,277 | Current status of experimental models for the study of malaria. | Parasitology | 2022 | https://conductscience.org/library/papers/35357277 | PubMed |
| 34,135,099 | Dissection-independent production of Plasmodium sporozoites from whole mosquitoes. | Life Sci Alliance | 2021 | https://conductscience.org/library/papers/34135099 | PubMed |
| 34,031,479 | Ultra-low dose immunization and multi-component vaccination strategies enhance protection against malaria in mice. | Sci Rep | 2021 | https://conductscience.org/library/papers/34031479 | PubMed |
| 31,231,377 | Vaccination With Sporozoites: Models and Correlates of Protection. | Front Immunol | 2019 | https://conductscience.org/library/papers/31231377 | PubMed |
| 30,510,775 | Pre-clinical evaluation of a P. berghei-based whole-sporozoite malaria vaccine candidate. | NPJ Vaccines | 2018 | https://conductscience.org/library/papers/30510775 | PubMed |
| 30,323,025 | Controlled Infection Immunization Using Delayed Death Drug Treatment Elicits Protective Immune Responses to Blood-Stage Malaria Parasites. | Infect Immun | 2019 | https://conductscience.org/library/papers/30323025 | PubMed |
| 30,155,278 | A Plasmodium berghei sporozoite-based vaccination platform against human malaria. | NPJ Vaccines | 2018 | https://conductscience.org/library/papers/30155278 | PubMed |
| 29,892,289 | Varying Immunizations With Plasmodium Radiation-Attenuated Sporozoites Alter Tissue-Specific CD8+ T Cell Dynamics. | Front Immunol | 2018 | https://conductscience.org/library/papers/29892289 | PubMed |
| 28,438,976 | Chemical Attenuation in the Development of a Whole-Organism Malaria Vaccine. | Infect Immun | 2017 | https://conductscience.org/library/papers/28438976 | PubMed |
| 28,199,305 | Sterile protection against human malaria by chemoattenuated PfSPZ vaccine. | Nature | 2017 | https://conductscience.org/library/papers/28199305 | PubMed |
| 28,077,589 | Trimethoprim-Sulfamethoxazole Prophylaxis During Live Malaria Sporozoite Immunization Induces Long-Lived, Homologous, and Heterologous Protective Immunity Against Sporozoite Challenge. | J Infect Dis | 2017 | https://conductscience.org/library/papers/28077589 | PubMed |
| 27,867,517 | Protective immunity to liver-stage malaria. | Clin Transl Immunology | 2016 | https://conductscience.org/library/papers/27867517 | PubMed |
| 27,855,488 | An expanding toolkit for preclinical pre-erythrocytic malaria vaccine development: bridging traditional mouse malaria models and human trials. | Future Microbiol | 2016 | https://conductscience.org/library/papers/27855488 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/324783
GET https://conductscience.org/api/papers/v1/324783/cited_by?page=2